Back to User profile » Professor Ying-Dong Li
Paper published by Professor Ying-Dong Li:
Original Research
Oncology
Feasibility and Safety of Anlotinib Plus Docetaxel versus Docetaxel Monotherapy in Patients with Previously Immunotherapy-Treated NSCLC: A Retrospective Exploratory Study
Li DW, Li YD, Jin H
International Journal of General Medicine 2025, 18:2319-2331
Published Date: 28 April 2025